Ruthirakuhan M

References (3)

Title : A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease - Herrmann_2016_J.Am.Med.Dir.Assoc_17_142
Author(s) : Herrmann N , O'Regan J , Ruthirakuhan M , Kiss A , Eryavec G , Williams E , Lanctot KL
Ref : J Am Med Dir Assoc , 17 :142 , 2016
Abstract : Herrmann_2016_J.Am.Med.Dir.Assoc_17_142
ESTHER : Herrmann_2016_J.Am.Med.Dir.Assoc_17_142
PubMedSearch : Herrmann_2016_J.Am.Med.Dir.Assoc_17_142
PubMedID: 26482056

Title : Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease - Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417
Author(s) : Ruthirakuhan M , Herrmann N , Suridjan I , Abraham EH , Farber I , Lanctot KL
Ref : Expert Opin Pharmacother , 17 :2417 , 2016
Abstract : Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417
ESTHER : Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417
PubMedSearch : Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417
PubMedID: 27825018

Title : Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments - Liu_2016_Curr.Alzheimer.Res_13_1134
Author(s) : Liu CS , Ruthirakuhan M , Chau SA , Herrmann N , Carvalho AF , Lanctot KL
Ref : Curr Alzheimer Res , 13 :1134 , 2016
Abstract : Liu_2016_Curr.Alzheimer.Res_13_1134
ESTHER : Liu_2016_Curr.Alzheimer.Res_13_1134
PubMedSearch : Liu_2016_Curr.Alzheimer.Res_13_1134
PubMedID: 27137221